What happened, in summary

Laurie was just past her 60th birthday and preparing to grow her health policy consulting work when a routine mammogram changed her plans. She had no family history of breast cancer, did not feel a lump, and initially thought the finding had to be wrong. A second mammogram, ultrasound, and biopsy confirmed invasive lobular carcinoma. Her doctors explained that ILC can grow slowly in wisps or lines, making it harder to feel as a mass or detect on routine imaging. The diagnosis also forced Laurie to postpone both her business plans and elective hip replacement surgery. She began reading everything she could about lobular breast cancer so she could understand her pathology report, treatment path, and prognosis. During post-surgery treatment, she found the Lobular Breast Cancer Alliance and felt less alone because the organization focused specifically on ILC research, detection, clinical trials, and patient education. As of April 2021, Laurie had moved from patient to advocate: she volunteered with LBCA and became its first executive director in May 2020. Her story centers on early detection, the uncertainty of an understudied breast cancer subtype, and how advocacy became part of her recovery and purpose. It also shows how patient communities can help people prepare better questions for their care teams.